Evidence map›Paper›PMID 42818145›Full record

ArticlemedRxiv : the preprint server for health sciences2026

LitBench: A Benchmark for Retrieval-Grounded Multi-Paper Evidence Synthesis in Epilepsy.

Alon Gorenshtei, Tianyu Zhang, M Brandon Westove, Daniel M Goldenholz

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alon GorenshteiDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0009-0000-7542-8608
Tianyu ZhangDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
M Brandon WestoveDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0003-4803-312X
Daniel M GoldenholzDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0002-8370-2758

Funding

Late-onset Unexplained Epilepsy as a Risk Factor for DementiaR01NS130119 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Alice D Lam · 2023 to 2026
$8.7M
Data-Driven Sleep Biomarkers of Brain Health, Heart Health, and MortalityR01HL161253 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CLIFFORD, GARI DAVID, MIGNOT, EMMANUEL J · 2022 to 2025
$8.3M
Comparative Safety of Seizure Prophylaxis within the Medicare ProgramR01AG073410 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Lidia Maria Veras Rocha de Moura · 2021 to 2026
$4.1M
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and InattentionR01AG073598 · NIA · STANFORD UNIVERSITY · PI Miles Berger · 2022 to 2026
$3.8M
Integrative Motor Activity Biomarker for the Risk of Alzheimer's RiskRF1AG064312 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI HU, KUN · 2019 to 2019
$3.6M
Prospective Validation of Neurophysiologic Outcome Prediction in Acute Brain InjuryR01NS126282 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Aaron F Struck, Michael Brandon Westover · 2023 to 2026
$2.9M
Establishing a Brain Health Index from the Sleep ElectroencephalogramRF1NS120947 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CASH, SYDNEY S, THOMAS, ROBERT JOSEPH · 2021 to 2021
$2.4M
Comparative Effectiveness of EEG-Guided Anti-Seizure Treatment in Acute Brain InjuryR01NS131347 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Sahar F Zafar · 2024 to 2026
$1.9M
Non-Invasive Seizure Forecasting System Using E-Diaries, Internal and External FactorsK23NS124656 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Daniel M Goldenholz · 2022 to 2026
$954k
SourceSpikeNet – A Biophysically Grounded AI Approach to Spike Detection in EEGR21NS142800 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Daniel M Goldenholz · 2026 to 2026
$252k
NHLBI NIH HHS R01 HL161253NIA NIH HHS R01 AG073410NIA NIH HHS R01 AG073598NIA NIH HHS RF1 AG064312NINDS NIH HHS K23 NS124656NINDS NIH HHS R01 NS126282NINDS NIH HHS R01 NS130119NINDS NIH HHS R01 NS131347NINDS NIH HHS R21 NS142800NINDS NIH HHS RF1 NS120947
6 · The paper itself

Abstract

Background: Clinicians increasingly use AI systems to search Methods: LitBench comprises 1,980 open-access papers (1,000 epilepsy papers holding the answers, 980 decoys from unrelated fields) and 9,472 human-reviewed facts, giving 2,188 single-paper questions and 170 requiring a fact from each of two papers. Difficulty rose by burying the answer among up to 2,000 distractors, then again over live PubMed Central. The same questions were then asked with the answering paper removed, so that refusal was the correct response. Four systems were tested: Gemma-4B, Gemma-12B, Sonnet-5, and DeepSeek-V4-Flash (refusal conditions only). Three model judges scored each answer by majority; two-paper questions counted only when both facts were found. Results: Across fixed-corpus single-paper conditions, accuracy ranged from 55.9% to 71.9% for Gemma-4B, 61.2% to 75.5% for Gemma-12B, and 90.0% to 91.3% for Sonnet-5. Similar epilepsy papers were harder than mixed candidate sets for both Gemma configurations. Two-paper accuracy was 5.7%, 17.1%, and 37.8%, respectively. With evidence absent, Gemma-12B refusal fell from 88.3% to 39.9% as candidate sets grew; Gemma-4B almost never refused. Sonnet-5 refused on 94.9% of sampled single-paper and all sampled two-paper cells. DeepSeek-V4-Flash also refused frequently, but on 80.3% of matched answer-present controls. Conclusions: No system was reliable across every axis tested: accuracy fell as competing papers were added, interpretation-requiring facts were harder than stated ones, two-paper synthesis was rarely achieved, and only some systems recognized absent evidence. What counts as "successful" literature search carries considerable nuance; LitBench can evaluate proposed tools ata fine-grained level.

Indexed as

AI agentbenchmarklarge language model

Identifiers

PMID42818145
PMCPMC13622311

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.